Colorectal Cancer Alliance shared a post on LinkedIn:
“Project Cure CRC has awarded 4 new grants
- Khosrow Rezvani, University of South Dakota – Nanoparticle-Based Targeted Delivery and Release of Veratridine: A Novel Strategy for Suppressing mTORC2 Signaling Pathway and Mitochondrial Metabolism in Colorectal Cancer ($200,000)
- Lisa Mielke, La Trobe University – New Immunotherapies Targeting gamma delta T cells in Colorectal Cancer ($309,533)
- Eric Christenson, The Johns Hopkins University – Leveraging circulating tumor DNA and peritoneal fluid tumor DNA to improve the management of patients with early stage colorectal cancer ($200,000)
- Heather O’Hagan, Indiana University Bloomington – Therapeutic targeting of the tumor stroma to improve therapy response in BRAFV600E colorectal cancer ($210,000)
Learn about the Alliance’s plan to cure CRC.”
